Isomorphic Labs
Last verified 2026-05-22. JSON
The funding figures on this page are attributed, not sourced: a publisher is on record but no document URL is. How we mark provenance.
| Total raised | $600.0Mattributed |
|---|---|
| Latest round | series-a, $600.0M, 2025-03-01attributed |
| Founded | 2021 |
| Headquarters | London |
| Industry | bio |
| Stage | series-a |
| Website | isomorphiclabs.com |
Isomorphic Labs is a DeepMind-spinout drug-discovery company building generative models that design small molecules and biologics, with AlphaFold-class structure prediction at the core. Customers are pharma partners Eli Lilly and Novartis funding co-developed clinical assets. Isomorphic combines AI design with classical wet-lab validation at portfolio scale.
Funding rounds
| Date | Round | Amount | Lead |
|---|---|---|---|
| 2025-03-01 | series-a | $600.0M | undisclosed |
Detected tech stack
Cloudflare, LottieFiles 5.13.0, Google Hosted Libraries, Cookiebot, Webflow, jquery 3.5.1
Provenance
| Fact | Status | Basis |
|---|---|---|
| Series A, $600.0M | attributed | sifted named as publisher. No document URL on file. |
| Total raised $600.0M | attributed | sifted named as publisher. No document URL on file. |
| Company existence | self-reported | isomorphiclabs.com, read 2026-05-22 |
| Description | self-reported | isomorphiclabs.com, read 2026-05-22 |
Nothing on this page is sourced yet. A sourced fact links to a document that states it.
Change history
No change recorded since records began on 2026-09-24.